Compare Aptus Pharma with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
INR 368 Cr (Micro Cap)
80.00
33
0.00%
-0.28
21.29%
16.14
Total Returns (Price + Dividend) 
Aptus Pharma for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News
What is the bonus history of Aptus Pharma?
Aptus Pharma has a recent bonus issue where they announced a 3:2 bonus. The ex-date for this bonus is set for May 12, 2026. This means that shareholders on record as of this date will receive additional shares in the ratio of 3 shares for every 2 shares they currently hold....
Read full news article Announcements 
Announcement under Regulation 30 (LODR)-Investor Presentation
29-May-2026 | Source : BSEAnnouncement Under Regulation 30 (LODR): Investor Presentation
Brand Promotion Initiative At Rajkot Hirasar Airport
22-May-2026 | Source : BSEIntimation under Regulation 30 of SEBI (LODR) Regulations 2015: Brand Promotion Initiative at Rajkot Hirasar Airport
Disclosure As Per Regulation 7(2) Of SEBI (PIT) Regulations 2015
15-May-2026 | Source : BSEDisclosure as per Regulation 7 (2) of SEBI (PIT) Regulations 2015
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
Aptus Pharma Ltd has announced 3:2 bonus issue, ex-date: 12 May 26
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : May 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Kapilbhai Hasmukhbhai Chandarana (0.11%)
None
23.76%
Half Yearly Results Snapshot (Standalone) - Mar'26
Growth in half year ended Mar 2026 is 123.92% vs 47.34% in Sep 2025
Growth in half year ended Mar 2026 is 64.00% vs 33.59% in Sep 2025
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is 89.62% vs 37.51% in Mar 2025
YoY Growth in year ended Mar 2026 is 56.08% vs 270.00% in Mar 2025






